Spyre Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spyre Therapeutics, Inc. has filed 821 SEC EDGAR filings since 24 Mar 2015

SEC filing history

Showing 1-25 of 821 matching filings.

Per page
25
Current page
1
SCHEDULE 13D/A File 005-89456

SCHEDULE 13D/A filing

Filing date
09 Oct 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-297063

424B5

Filing date
05 Oct 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2026
Reporting date
01 Oct 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2026
Reporting date
01 Oct 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2026
Reporting date
30 Sep 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37722

144 filing

Filing date
01 Oct 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37722

144 filing

Filing date
01 Oct 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-89456

SCHEDULE 13G filing

Filing date
01 Oct 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37722

144 filing

Filing date
30 Sep 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Sep 2026
Reporting date
01 Sep 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Sep 2026
Reporting date
01 Sep 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Sep 2026
Reporting date
01 Sep 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37722

144 filing

Filing date
01 Sep 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-89456

SCHEDULE 13G/A filing

Filing date
14 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-89456

SCHEDULE 13G/A filing

Filing date
14 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Aug 2026
Reporting date
07 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37722

144 filing

Filing date
07 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37722

144 filing

Filing date
07 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Aug 2026
Reporting date
03 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Aug 2026
Reporting date
03 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .